Skip to main content

Table 1 The demographic features of the involved patients with baldder cancer and chronic cystitis.

From: Tumor markers of bladder cancer: the schistosomal bladder tumors versus non-schistosomal bladder tumors

Demographic feature

Value

Bladder cancer

Number of patients:

 

SBT

45 (53.57%)

NSBT

39 (46.43%)

Sex of patients:

 

SBT

38 men and 7 women

NSBT

25 men and 14 women

Recurrence of bladder cancer:

 

First presentation

61 (72.62%)

Recurrent

23 (27.38%)

Age of patients:

 

SBT

Range: 38–64 years, mean: 51.4 ± 6.2 years

NSBT

Range: 46–72, mean: 66.5 ± 5.3 years

Type of tumor growth:

 

SBT

37 papillary

8 sessile

NSBT

34 papillary

4 sessile

1 nodular

Tumor muscle invasiveness:

 

Invasive (T2, T3, and T4)

62 (73.81%) patients

Non invasive (Ta, T1, and CIS)

22 (26.19%) patients

Grading:

 

Low grade (grade 1 and 2)

35 (41.66%) patients

High grade (grade 3)

49 (58.33%) patients

Histopathology of bladder tumors:

 

SCC

52 (61.91%) patients

TCC

32 (38.09%) patients

Staging of bladder cancer patients:

 

Stage I

9 (10.71%)

Stage II

13 (15.47%)

Stage III

18 (21.42%)

Stage IV

44 (52.38%)

Chronic cystitis

Number of patients:

 

SC

16 (36.36%)

NSC

28 cases (63.64%)

Sex of patients:

 

SC

14 men and 2 women

NSC

15 men and 13 women

Age of patients:

 

SC

mean age 62.5 ± 3.5 years

NSC

mean age 53.4 ± 4.2 years